Global pharma logistics services are shifting from store and ship to end-to-end commercialization support. As regulatory expectations rise and advanced therapies push cold-chain complexity, 3PLs are investing in validated infrastructure, network-wide quality systems, and data-driven visibility.
May 22, 2026
Image credit: Cencora.
Pharmaceutical third-party logistics (3PL) providers are moving beyond traditional warehousing into more holistic and strategic commercialization support. At the same time, rising demand for temperature-sensitive biologics and increasingly strict regulations necessitates 3PLs to build and scale advanced cold chain capabilities and maintain a forward-looking approach to evolving regulations, digital technologies, and industry trends.
Cencora is one organization leaning into these shifts. We spoke with Albert Cooksey, senior vice-president and general manager of 3PL Services for ICS, a Cencora company, about what he’s seeing in the market and how 3PLs are evolving to keep pace.
